| pubmed-article:8654467 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0042963 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0027497 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0010583 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0061851 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:8654467 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:8654467 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8654467 | pubmed:dateCreated | 1996-8-1 | lld:pubmed |
| pubmed-article:8654467 | pubmed:abstractText | Ondansetron was found to be effective as an antiemetic in numerous clinical trials of highly emetogenic combination-chemotherapy regimens that included cisplatin. Its role in milder emetogenic regimes has not been fully defined. | lld:pubmed |
| pubmed-article:8654467 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8654467 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8654467 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8654467 | pubmed:issn | 0392-2936 | lld:pubmed |
| pubmed-article:8654467 | pubmed:author | pubmed-author:KuhnWW | lld:pubmed |
| pubmed-article:8654467 | pubmed:author | pubmed-author:ConradAA | lld:pubmed |
| pubmed-article:8654467 | pubmed:author | pubmed-author:MedesGG | lld:pubmed |
| pubmed-article:8654467 | pubmed:author | pubmed-author:MeissnerOO | lld:pubmed |
| pubmed-article:8654467 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8654467 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:8654467 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8654467 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8654467 | pubmed:pagination | 114-22 | lld:pubmed |
| pubmed-article:8654467 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:meshHeading | pubmed-meshheading:8654467-... | lld:pubmed |
| pubmed-article:8654467 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8654467 | pubmed:articleTitle | Improved control of nausea and emesis with a new bromazepam-containing ondansetron regimen in ovarian cancer patients receiving chemotherapy with carboplatin and cyclophosphamide. | lld:pubmed |
| pubmed-article:8654467 | pubmed:affiliation | Department of Obstetrics and Gynecology, University of Göttingen, Germany. | lld:pubmed |
| pubmed-article:8654467 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8654467 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8654467 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8654467 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
